This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02896/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02896/identifier/drugbank/
n10http://linked.opendata.cz/resource/mesh/concept/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02896/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02896/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02896
rdf:type
n3:Drug
n3:description
An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB02896 n8:DB02896
dcterms:title
Methylthioinosine
adms:identifier
n12:MTP n13:46936521 n14:DB02896 n15:46505005
n3:synonym
6-Methyl MP-riboside 6-Methylthioinosine beta-D-Ribosyl-6-methylthiopurine 6-Methyl MP riboside Methylmercaptopurine riboside MMPR 6-methyl-9-ribofuranosyl-purine-6-thiol 6-(methylthio)-9-beta-d-ribofuranosyl-9H-purine 6-MMPR 6-Methylmercaptopurine riboside 6-(Methylthio)purine ribonucleoside Me6MPR 6-Methylmercaptopurine ribonucleoside 6-Methylmercaptopurine 6-Methyl-9-ribofuranosylpurine-6-thiol 6-Methylthiopurine riboside
n3:toxicity
IPR-RAT LD<sub>50</sub>: 65 mg/kg
n9:hasConcept
n10:M0013668
n3:IUPAC-Name
n4:271B62F3-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B62F9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B62F8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B62F5-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B62F6-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B62F7-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B62F1-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B630A-363D-11E5-9242-09173F13E4C5 n4:271B62F2-363D-11E5-9242-09173F13E4C5 n4:271B62EF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B62F0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B62FF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6300-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B62FA-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B62FB-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B62FD-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B62FC-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B62FE-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
342-69-8
n3:Bioavailability
n4:271B6305-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6307-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6308-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B6309-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6304-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6303-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6306-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B62F4-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6301-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6302-363D-11E5-9242-09173F13E4C5